Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Savara Inc (NQ: SVRA )

1.700 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 11, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.700
Bid (Size) 1.520 (1)
Ask (Size) 1.760 (3)
Prev. Close 1.700
Today's Range 1.700 - 1.700
52wk Range 1.020 - 1.910
Shares Outstanding 114,042,642
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Savara Q2 Earnings
  Savara (NASDAQ:SVRA) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Savara reported in-line EPS of... 
Via Benzinga
Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire

Performance

YTD
+25.00%
+25.00%
1 Month
-8.60%
-8.60%
3 Month
+49.12%
+49.12%
6 Month
+34.92%
+34.92%
1 Year
+38.21%
+38.21%

More News

Read More
Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022
From Savara Inc.
Via Business Wire
Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic
From Savara Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Savara to Present at Jefferies Healthcare Conference
From Savara Inc.
Via Business Wire
Savara to Present at H.C. Wainwright Global Investment Conference
From Savara Inc.
Via Business Wire
Savara: Q1 Earnings Insights
Via Benzinga
Savara Reports First Quarter 2022 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
The Daily Biotech Pulse: WHO Endorses Pfizer's Oral COVID Therapy, Vallon Pharma Surges On Strategic Review, Novavax Starts Dosing In Adolescents COVID Booster Trial
Via Benzinga
Savara Announces Debt Refinancing of $26.5M Credit Facility With Silicon Valley Bank
From Savara Inc.
Via Business Wire
Savara Reports Fourth Quarter / Year-End 2021 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Savara to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
From Savara Inc.
Via Business Wire
5 Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
Savara to Participate in Two Upcoming Investor Healthcare Conferences
From Savara Inc.
Via Business Wire
Savara Reports Third Quarter 2021 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara to Present at the Jefferies London Healthcare Conference
From Savara Inc.
Via Business Wire
Savara to Present at the Inaugural Piper Sandler Lung Day
From Savara Inc.
Via Business Wire
3 Penny Stocks Insiders Are Buying
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.